- Home
- CRBP vs SNT Comparison
CRBP vs SNT Comparison
Compare CRBP & SNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRBP
- SNT
- Stock Information
- Founded
- CRBP 2009
- SNT 1965
- Country
- CRBP United States
- SNT Canada
- Employees
- CRBP N/A
- SNT N/A
- Industry
- CRBP Biotechnology: Pharmaceutical Preparations
- SNT Telecommunications Equipment
- Sector
- CRBP Health Care
- SNT Telecommunications
- Exchange
- CRBP Nasdaq
- SNT Nasdaq
- Market Cap
- CRBP 73.4M
- SNT 74.4M
- IPO Year
- CRBP N/A
- SNT 1993
- Fundamental
- Price
- CRBP $6.45
- SNT $3.50
- Analyst Decision
- CRBP Strong Buy
- SNT
- Analyst Count
- CRBP 10
- SNT 0
- Target Price
- CRBP $53.56
- SNT N/A
- AVG Volume (30 Days)
- CRBP 147.8K
- SNT 14.9K
- Earning Date
- CRBP 05-06-2025
- SNT 06-12-2025
- Dividend Yield
- CRBP N/A
- SNT N/A
- EPS Growth
- CRBP N/A
- SNT N/A
- EPS
- CRBP N/A
- SNT 0.11
- Revenue
- CRBP N/A
- SNT $35,753,000.00
- Revenue This Year
- CRBP N/A
- SNT N/A
- Revenue Next Year
- CRBP $150.00
- SNT N/A
- P/E Ratio
- CRBP N/A
- SNT $30.45
- Revenue Growth
- CRBP N/A
- SNT 9.03
- 52 Week Low
- CRBP $4.64
- SNT $1.27
- 52 Week High
- CRBP $61.90
- SNT $3.97
- Technical
- Relative Strength Index (RSI)
- CRBP 46.87
- SNT 57.57
- Support Level
- CRBP $6.10
- SNT $3.25
- Resistance Level
- CRBP $8.07
- SNT $3.55
- Average True Range (ATR)
- CRBP 0.71
- SNT 0.14
- MACD
- CRBP -0.10
- SNT 0.02
- Stochastic Oscillator
- CRBP 13.31
- SNT 72.41
About CRBP Corbus Pharmaceuticals Holdings Inc.
Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.
About SNT Senstar Technologies Ltd.
Senstar Technologies Corp is a provider of comprehensive physical, video, and access control security products and solutions. Its perimeter intrusion detection systems (including fence sensors, buried sensors, and above-ground sensors), intelligent video management, video analytics, and access control offer a comprehensive suite of integrated solutions that reduce complexity, improve performance, and unify support.